ESC Premium Access

Predictors of stroke and overall mortality in real world patients with atrial fibrillation treated with oral anticoagulants.

Congress Session

About the speaker

Doctor Manuel P Anguita Sanchez

University Hospital Queen Sofia, Cordoba (Spain)
1 presentation
0 follower

8 more presentations in this session

Temporal relations between atrial fibrillation and ischemic stroke and their prognostic impact on mortality

Speaker: Doctor S. Camen (Hamburg, DE)


Clinical Efficacy and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients with Non-Valvular Atrial Fibrillation: Results from a Nationwide Cohort Study

Speaker: Doctor M. Cho (Seoul, KR)


Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial

Speaker: Professor A. Goette (Paderborn, DE)


The global ETNA-AF registry programme: snapshot baseline demographics and patient characteristics from more than 17,700 atrial fibrillation patients on edoxaban

Speaker: Doctor Y. Koretsune (Osaka, JP)


Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation

Speaker: Doctor Y. Yao (Beijing, CN)


Access the full session

Poster Session 1 - Atrial fibrillation - Stroke Prevention

Speakers: Doctor M. Anguita Sanchez, Doctor S. Camen, Doctor M. Cho, Professor A. Goette, Doctor Y. Koretsune...

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk